Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 28;12(2):e053183.
doi: 10.1136/bmjopen-2021-053183.

Patient and practitioner views on a combined face-to-face and digital intervention to support medication adherence in hypertension: a qualitative study within primary care

Affiliations

Patient and practitioner views on a combined face-to-face and digital intervention to support medication adherence in hypertension: a qualitative study within primary care

Miranda Van Emmenis et al. BMJ Open. .

Abstract

Objectives: To explore patients' and healthcare practitioners' (HCPs) views about non-adherence to hypertension medication and potential content of a combined very brief face-to-face discussion (VBI) and digital intervention (DI).

Methods: A qualitative study (N=31): interviews with patients with hypertension (n=6) and HCPs (n=11) and four focus groups with patients with hypertension (n=14). Participants were recruited through general practices in Eastern England and London. Topic guides explored reasons for medication non-adherence and attitudes towards a potential intervention to support adherence. Stimuli to facilitate discussion included example SMS messages and smartphone app features, including mobile sensing. Analysis was informed methodologically by the constant comparative approach and theoretically by perceptions and practicalities approach.

Results: Participants' overarching explanations for non-adherence were non-intentional (forgetting) and intentional (concerns about side effects, reluctance to medicate). These underpinned their views on intervention components: messages that targeted forgetting medication or obtaining prescriptions were considered more useful than messages providing information on consequences of non-adherence. Tailoring the DI to the individuals' needs, regarding timing and number of messages, was considered important for user engagement. Patients wanted control over the DI and information about data use associated with any location sensing. While the DI was considered limited in its potential to address intentional non-adherence, HCPs saw the potential for a VBI in addressing this gap, if conducted in a non-judgemental manner. Incorporating a VBI into routine primary care was considered feasible, provided it complemented existing GP practice software and HCPs received sufficient training.

Conclusions: A combined VBI-DI can potentially address intentional and non-intentional reasons for non-adherence to hypertension medication. For optimal engagement, recommendations from this work include a VBI conducted in a non-judgmental manner and focusing on non-intentional factors, followed by a DI that is easy-to-use, highly tailored and with provision of data privacy details about any sensing technology used.

Keywords: hypertension; primary care; public health; qualitative research.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Example digital intervention content to generate discussion in interviews and focus groups; medication reminder notification, feedback on medication adherence levels (weekly and monthly), SMS support message

References

    1. Sabaté E. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization, 2003.
    1. Chowdhury R, Khan H, Heydon E, et al. . Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences. Eur Heart J 2013;34:2940–8. 10.1093/eurheartj/eht295 - DOI - PubMed
    1. Gupta P, Patel P, Štrauch B, et al. . Risk factors for nonadherence to antihypertensive treatment. Hypertension 2017;69:1113–20. 10.1161/HYPERTENSIONAHA.116.08729 - DOI - PubMed
    1. Forouzanfar MH, Liu P, Roth GA, et al. . Global burden of hypertension and systolic blood pressure of at least 110 to 115 MM Hg, 1990-2015. JAMA 2017;317:165–82. 10.1001/jama.2016.19043 - DOI - PubMed
    1. Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol 2020;16:223–37. 10.1038/s41581-019-0244-2 - DOI - PMC - PubMed

Publication types